1. Malla RR, Patnala K, Kumar DKG, Marni R. Drug resistance in gynecologic cancers: emphasis on noncoding RNAs and drug efflux mechanisms. In: Riyaz B, Safraz A, editors. Overcoming drug resistance in gynecologic cancers. Amsterdam: Elsevier; 2021.
2. Maheshwari A, Kumar N, Mahanshetty U. Gynecological cancers: a summary of published Indian data. South Asian J Cancer. 2016;5:112–20.
3. Saha P, Kumar A, Bhanja J, Shaik R, Kawale AL, Kumar R: A Review of Immune Blockade Safety and Antitumor Activity of Dostarlimab Therapy in Endometrial Cancer. International Journal for Research in Applied Sciences and Biotechnology 2022, 9:201-209.
4. Lin K-T, Sun S-P, Wu J-I, Wang L. Low-dose glucocorticoids suppresses ovarian tumor growth and metastasis in an immunocompetent syngeneic mouse model. PLoS ONE. 2017;12:e0178937.
5. Almadrones-Cassidy LA. Gynecologic cancers. Pittsburgh: Oncology Nursing Society; 2010.